Literature DB >> 23408601

Correlates of bone microarchitectural parameters and serum sclerostin levels in men: the STRAMBO study.

Pawel Szulc1, Stéphanie Boutroy, Nicolas Vilayphiou, Michael Schoppet, Martina Rauner, Roland Chapurlat, Christine Hamann, Lorenz C Hofbauer.   

Abstract

Sclerostin is predominantly expressed by osteocytes. Serum sclerostin levels are positively correlated with areal bone mineral density (aBMD) measured by dual-energy X-ray absorptiometry (DXA) and bone microarchitecture assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT) in small studies. We assessed the relation of serum sclerostin levels with aBMD and microarchitectural parameters based on HR-pQCT in 1134 men aged 20 to 87 years using multivariable models adjusted for confounders (age, body size, lifestyle, comorbidities, hormones regulating bone metabolism, muscle mass and strength). The apparent age-related increase in serum sclerostin levels was faster before the age of 63 years than afterward (0.43 SD versus 0.20 SD per decade). In 446 men aged ≤63 years, aBMD (spine, hip, whole body), trabecular volumetric BMD (Tb.vBMD), and trabecular number (Tb.N) at the distal radius and tibia were higher in the highest sclerostin quartile versus the three lower quartiles combined. After adjustment for aBMD, men in the highest sclerostin quartile had higher Tb.vBMD (mainly in the central compartment) and Tb.N at both skeletal sites (p < 0.05 to 0.001). In 688 men aged >63 years, aBMD was positively associated with serum sclerostin levels at all skeletal sites. Cortical vBMD (Ct.vBMD) and cortical thickness (Ct.Th) were lower in the first sclerostin quartile versus the three higher quartiles combined. Tb.vBMD increased across the sclerostin quartiles, and was associated with lower Tb.N and more heterogeneous trabecular distribution (higher Tb.Sp.SD) in men in the lowest sclerostin quartile. After adjustment for aBMD, men in the lowest sclerostin quartile had lower Tb.vBMD and Tb.N, but higher Tb.Sp.SD (p < 0.05 to 0.001) at both the skeletal sites. In conclusion, serum sclerostin levels in men are strongly positively associated with better bone microarchitectural parameters, mainly trabecular architecture, regardless of the potential confounders.
Copyright © 2013 American Society for Bone and Mineral Research.

Entities:  

Keywords:  BONE MICROARCHITECTURE; MEN; SCLEROSTIN; TRABECULAR BONE

Mesh:

Substances:

Year:  2013        PMID: 23408601     DOI: 10.1002/jbmr.1888

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  22 in total

Review 1.  Muscle-bone interactions: basic and clinical aspects.

Authors:  Luisella Cianferotti; Maria Luisa Brandi
Journal:  Endocrine       Date:  2013-08-29       Impact factor: 3.633

2.  Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study.

Authors:  Thomas C Register; Keith A Hruska; Jasmin Divers; Donald W Bowden; Nicholette D Palmer; J Jeffrey Carr; Lynne E Wagenknecht; R Caresse Hightower; Jianzhao Xu; S Carrie Smith; Dennis J Dietzen; Carl D Langefeld; Barry I Freedman
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

3.  Circulating sclerostin and dickkopf-1 levels in ossification of the posterior longitudinal ligament of the spine.

Authors:  Masafumi Kashii; Yohei Matuso; Tsuyoshi Sugiura; Takahito Fujimori; Yukitaka Nagamoto; Takahiro Makino; Takashi Kaito; Kosuke Ebina; Motoki Iwasaki; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2015-06-04       Impact factor: 2.626

4.  Circulating sclerostin associated with vertebral bone marrow fat in older men but not women.

Authors:  Yu-Heng Vivian Ma; Ann V Schwartz; Sigurdur Sigurdsson; Trisha F Hue; Thomas F Lang; Tamara B Harris; Clifford J Rosen; Eric Vittinghoff; Gudny Eiriksdottir; Alda M Hauksdottir; Kristin Siggeirsdottir; Gunnar Sigurdsson; Diana Oskarsdottir; Nicola Napoli; Lisa Palermo; Vilmundur Gudnason; Xiaojuan Li
Journal:  J Clin Endocrinol Metab       Date:  2014-12       Impact factor: 5.958

5.  Teenagers and young adults with nephropathic cystinosis display significant bone disease and cortical impairment.

Authors:  Aurélia Bertholet-Thomas; Debora Claramunt-Taberner; Ségolène Gaillard; Georges Deschênes; Elisabeth Sornay-Rendu; Pawel Szulc; Martine Cohen-Solal; Solenne Pelletier; Marie-Christine Carlier; Pierre Cochat; Justine Bacchetta
Journal:  Pediatr Nephrol       Date:  2018-02-12       Impact factor: 3.714

6.  Circulating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.

Authors:  J Coulson; L Bagley; Y Barnouin; S Bradburn; G Butler-Browne; H Gapeyeva; J-Y Hogrel; T Maden-Wilkinson; A B Maier; C Meskers; C Murgatroyd; M Narici; M Pääsuke; L Sassano; S Sipilä; N Al-Shanti; L Stenroth; D A Jones; J S McPhee
Journal:  Osteoporos Int       Date:  2017-06-05       Impact factor: 4.507

7.  Plasma Sclerostin in HIV-Infected Adults on Effective Antiretroviral Therapy.

Authors:  Kristine M Erlandson; MaryAnn O'Riordan; Corrilynn O Hileman; Eric Rapaport; Danielle Labbato; Thomas B Campbell; Grace A McComsey
Journal:  AIDS Res Hum Retroviruses       Date:  2015-05-27       Impact factor: 2.205

8.  Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?

Authors:  S Pelletier; C B Confavreux; J Haesebaert; F Guebre-Egziabher; J Bacchetta; M-C Carlier; L Chardon; M Laville; R Chapurlat; G M London; M-H Lafage-Proust; D Fouque
Journal:  Osteoporos Int       Date:  2015-04-25       Impact factor: 4.507

9.  Sclerostin Immunoreactivity Increases in Cortical Bone Osteocytes and Decreases in Articular Cartilage Chondrocytes in Aging Mice.

Authors:  Michelle L Thompson; Juan Miguel Jimenez-Andrade; Patrick W Mantyh
Journal:  J Histochem Cytochem       Date:  2015-12-23       Impact factor: 2.479

Review 10.  Sex steroid actions in male bone.

Authors:  Dirk Vanderschueren; Michaël R Laurent; Frank Claessens; Evelien Gielen; Marie K Lagerquist; Liesbeth Vandenput; Anna E Börjesson; Claes Ohlsson
Journal:  Endocr Rev       Date:  2014-09-09       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.